Researchers discover potential strategy to reprogram glioblastoma cells and slow tumor growth

Common antidepressants could help the immune system fight cancer, UCLA study finds

A widely used antidepressant drug could help the immune system fight cancer, according to a new research study from UCLA.

May 23, 2025

Vol.51 No.20

Clinical Roundup

Shorter radiation therapy after prostate surgery safe, UCLA study finds

For men who undergo a radical prostatectomy for the treatment of prostate cancer, post-surgery radiation therapy can play a vital role in reducing the risk of recurrence.

May 16, 2025

Vol.51 No.19

Clinical Roundup

New compound targets circadian clock machinery in cells to fight glioblastoma

A series of preclinical studies show that a new compound, SHP1705, targets circadian clock proteins hijacked by glioblastoma stem cells, impairing the cancer cells’ ability to survive and grow.

May 16, 2025

Vol.51 No.19

Clinical Roundup

Zinc-transporting protein contributes to aggressive growth of brain tumor, study shows

University of Oklahoma researchers have discovered one reason why the brain tumor glioblastoma is so aggressive.

May 09, 2025

Vol.51 No.18

Clinical Roundup

UCLA test predicts which prostate cancer patients are most likely to develop long-term side effects from radiation therapy

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have validated a test that can accurately predict which patients with prostate cancer are at higher risk of developing long-lasting urinary side effects after receiving radiation therapy.

April 11, 2025

Vol.51 No.14

Clinical Roundup

UT Health San Antonio-led research discovers how to slow or block recurrence of glioblastoma

Researchers at the University of Texas Health Science Center at San Antonio have discovered a way to delay or even block recurrence of the deadliest brain cancer after radiation.

March 28, 2025

Vol.51 No.12

Researchers discover potential strategy to reprogram glioblastoma cells and slow tumor growth

YOU MAY BE INTERESTED IN

Common antidepressants could help the immune system fight cancer, UCLA study finds

Shorter radiation therapy after prostate surgery safe, UCLA study finds

New compound targets circadian clock machinery in cells to fight glioblastoma

Zinc-transporting protein contributes to aggressive growth of brain tumor, study shows

UCLA test predicts which prostate cancer patients are most likely to develop long-term side effects from radiation therapy

UT Health San Antonio-led research discovers how to slow or block recurrence of glioblastoma

Renew today!

Subscriber content

Never miss an issue!

Login